Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.
Saved in:
| Title: | Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function. |
|---|---|
| Authors: | Fernandes LM; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States., Tresemer J; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States., Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, United States., Rios JJ; Center for Pediatric Bone Biology and Translational Research, Scottish Rite for Children, Dallas, TX, United States.; McDermott Center for Human Growth and Development, Dallas, TX, United States., Scallan JP; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Dellinger MT; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.; Department of Surgery, UT Southwestern Medical Center, Dallas, TX, United States. |
| Source: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2023 Sep 25; Vol. 11, pp. 1276333. Date of Electronic Publication: 2023 Sep 25 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
